UK ups drive for TSE (transmissible spongiform encephalopathy) diagnostic
This article was originally published in Clinica
The international race to improve the diagnosis, treatment and transmission risk assessment of transmissible spongiform encephalopathies has received a major boost from a UK research funding group. £7 million ($10 million) has been awarded to fund a programme of 22 UK and EU public and private sector collaborations in fields that range from subclinical diagnosis of the disease to ways of assessing the effectiveness of surgical device sterilisation.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.